Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: Phenotypic and molecular characterization

Dong Li, Evan E. Opas, Florin Tuluc, Daniel L. Metzger, Cuiping Hou, Hakon Hakonarson, Michael A. Levine

Research output: Contribution to journalArticle

Abstract

Context: Most cases of autosomal dominant hypoparathyroidism (ADH) are caused by gain-offunction mutations in CASR or dominant inhibitor mutations in GCM2 or PTH. Copyright

Objective: Our objectives were to identify the genetic basis for ADH in a multigenerational family and define the underlying disease mechanism.

Subjects: Here we evaluated a multigenerational family with ADH in which affected subjects had normal sequences in these genes and were shorter than unaffected family members.

Methods: Wecollected clinical and biochemical data from 6 of 11 affected subjects and performed whole-exome sequence analysis on DNA from two affected sisters and their affected father. Functional studies were performed after expression of wild-type and mutant Gα11proteins in human embryonic kidney-293-CaR cells that stably express calcium-sensing receptors.

Results: Whole-exome-sequencing followed by Sanger sequencing revealed a heterozygous mutation, c.179G>T; p.R60L, in GNA11, which encodes the α-subunit of G11, the principal heterotrimeric G protein that couples calcium-sensing receptors to signal activation in parathyroid cells. Functional studies of Gα11R60L showed increased accumulation of intracellular concentration of free calcium in response to extracellular concentration of free calcium with a significantly decreased EC50 compared with wild-type Gα11. By contrast, R60L was significantly less effective than the oncogenicQ209Lform ofGα11asanactivator of theMAPKpathway.Comparedto subjects with CASR mutations, patients with GNA11 mutations lacked hypercalciuria and had normal serum magnesium levels.

Conclusions:Ourfindings indicate that the germline gain-of-function mutation ofGNA11is a cause of ADH and implicate a novel role for GNA11 in skeletal growth.

Original languageEnglish (US)
Pages (from-to)E1774-E1783
JournalJournal of Clinical Endocrinology and Metabolism
Volume99
Issue number9
DOIs
StatePublished - Sep 1 2014
Externally publishedYes

Fingerprint

Calcium-Sensing Receptors
Germ-Line Mutation
Calcium
Heterotrimeric GTP-Binding Proteins
Mutation
Magnesium
Exome
Genes
Chemical activation
DNA
Hypercalciuria
DNA Sequence Analysis
Fathers
Familial Hypercalciuric Hypocalcemia
Siblings
Kidney
Growth
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11 : Phenotypic and molecular characterization. / Li, Dong; Opas, Evan E.; Tuluc, Florin; Metzger, Daniel L.; Hou, Cuiping; Hakonarson, Hakon; Levine, Michael A.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 99, No. 9, 01.09.2014, p. E1774-E1783.

Research output: Contribution to journalArticle

Li, Dong ; Opas, Evan E. ; Tuluc, Florin ; Metzger, Daniel L. ; Hou, Cuiping ; Hakonarson, Hakon ; Levine, Michael A. / Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11 : Phenotypic and molecular characterization. In: Journal of Clinical Endocrinology and Metabolism. 2014 ; Vol. 99, No. 9. pp. E1774-E1783.
@article{eb8d910bd4324103b365f8eb0727c7d2,
title = "Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: Phenotypic and molecular characterization",
abstract = "Context: Most cases of autosomal dominant hypoparathyroidism (ADH) are caused by gain-offunction mutations in CASR or dominant inhibitor mutations in GCM2 or PTH. CopyrightObjective: Our objectives were to identify the genetic basis for ADH in a multigenerational family and define the underlying disease mechanism.Subjects: Here we evaluated a multigenerational family with ADH in which affected subjects had normal sequences in these genes and were shorter than unaffected family members.Methods: Wecollected clinical and biochemical data from 6 of 11 affected subjects and performed whole-exome sequence analysis on DNA from two affected sisters and their affected father. Functional studies were performed after expression of wild-type and mutant Gα11proteins in human embryonic kidney-293-CaR cells that stably express calcium-sensing receptors.Results: Whole-exome-sequencing followed by Sanger sequencing revealed a heterozygous mutation, c.179G>T; p.R60L, in GNA11, which encodes the α-subunit of G11, the principal heterotrimeric G protein that couples calcium-sensing receptors to signal activation in parathyroid cells. Functional studies of Gα11R60L showed increased accumulation of intracellular concentration of free calcium in response to extracellular concentration of free calcium with a significantly decreased EC50 compared with wild-type Gα11. By contrast, R60L was significantly less effective than the oncogenicQ209Lform ofGα11asanactivator of theMAPKpathway.Comparedto subjects with CASR mutations, patients with GNA11 mutations lacked hypercalciuria and had normal serum magnesium levels.Conclusions:Ourfindings indicate that the germline gain-of-function mutation ofGNA11is a cause of ADH and implicate a novel role for GNA11 in skeletal growth.",
author = "Dong Li and Opas, {Evan E.} and Florin Tuluc and Metzger, {Daniel L.} and Cuiping Hou and Hakon Hakonarson and Levine, {Michael A.}",
year = "2014",
month = "9",
day = "1",
doi = "10.1210/jc.2014-1029",
language = "English (US)",
volume = "99",
pages = "E1774--E1783",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11

T2 - Phenotypic and molecular characterization

AU - Li, Dong

AU - Opas, Evan E.

AU - Tuluc, Florin

AU - Metzger, Daniel L.

AU - Hou, Cuiping

AU - Hakonarson, Hakon

AU - Levine, Michael A.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Context: Most cases of autosomal dominant hypoparathyroidism (ADH) are caused by gain-offunction mutations in CASR or dominant inhibitor mutations in GCM2 or PTH. CopyrightObjective: Our objectives were to identify the genetic basis for ADH in a multigenerational family and define the underlying disease mechanism.Subjects: Here we evaluated a multigenerational family with ADH in which affected subjects had normal sequences in these genes and were shorter than unaffected family members.Methods: Wecollected clinical and biochemical data from 6 of 11 affected subjects and performed whole-exome sequence analysis on DNA from two affected sisters and their affected father. Functional studies were performed after expression of wild-type and mutant Gα11proteins in human embryonic kidney-293-CaR cells that stably express calcium-sensing receptors.Results: Whole-exome-sequencing followed by Sanger sequencing revealed a heterozygous mutation, c.179G>T; p.R60L, in GNA11, which encodes the α-subunit of G11, the principal heterotrimeric G protein that couples calcium-sensing receptors to signal activation in parathyroid cells. Functional studies of Gα11R60L showed increased accumulation of intracellular concentration of free calcium in response to extracellular concentration of free calcium with a significantly decreased EC50 compared with wild-type Gα11. By contrast, R60L was significantly less effective than the oncogenicQ209Lform ofGα11asanactivator of theMAPKpathway.Comparedto subjects with CASR mutations, patients with GNA11 mutations lacked hypercalciuria and had normal serum magnesium levels.Conclusions:Ourfindings indicate that the germline gain-of-function mutation ofGNA11is a cause of ADH and implicate a novel role for GNA11 in skeletal growth.

AB - Context: Most cases of autosomal dominant hypoparathyroidism (ADH) are caused by gain-offunction mutations in CASR or dominant inhibitor mutations in GCM2 or PTH. CopyrightObjective: Our objectives were to identify the genetic basis for ADH in a multigenerational family and define the underlying disease mechanism.Subjects: Here we evaluated a multigenerational family with ADH in which affected subjects had normal sequences in these genes and were shorter than unaffected family members.Methods: Wecollected clinical and biochemical data from 6 of 11 affected subjects and performed whole-exome sequence analysis on DNA from two affected sisters and their affected father. Functional studies were performed after expression of wild-type and mutant Gα11proteins in human embryonic kidney-293-CaR cells that stably express calcium-sensing receptors.Results: Whole-exome-sequencing followed by Sanger sequencing revealed a heterozygous mutation, c.179G>T; p.R60L, in GNA11, which encodes the α-subunit of G11, the principal heterotrimeric G protein that couples calcium-sensing receptors to signal activation in parathyroid cells. Functional studies of Gα11R60L showed increased accumulation of intracellular concentration of free calcium in response to extracellular concentration of free calcium with a significantly decreased EC50 compared with wild-type Gα11. By contrast, R60L was significantly less effective than the oncogenicQ209Lform ofGα11asanactivator of theMAPKpathway.Comparedto subjects with CASR mutations, patients with GNA11 mutations lacked hypercalciuria and had normal serum magnesium levels.Conclusions:Ourfindings indicate that the germline gain-of-function mutation ofGNA11is a cause of ADH and implicate a novel role for GNA11 in skeletal growth.

UR - http://www.scopus.com/inward/record.url?scp=84907213108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907213108&partnerID=8YFLogxK

U2 - 10.1210/jc.2014-1029

DO - 10.1210/jc.2014-1029

M3 - Article

C2 - 24823460

AN - SCOPUS:84907213108

VL - 99

SP - E1774-E1783

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -